NATHAN MISEL: Open Payments
NPI 1558557165 · BELPRE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,755 in 114 payments from 17 companies in 2025. Trend: 2023 $3,744 · 2024 $8,987 · 2025 $1,755
Food & beverage: $1,647Education: $108
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $332 |
| Regeneron Healthcare Solutions, Inc. | 10 | $278 |
| Janssen Biotech, Inc. | 11 | $198 |
| Amgen Inc. | 13 | $192 |
| Galderma Laboratories, L.P. | 15 | $158 |
| Lilly USA, LLC | 10 | $152 |
| E.R. Squibb & Sons, L.L.C. | 6 | $100 |
| Novartis Pharmaceuticals Corporation | 3 | $62 |
| UCB, Inc. | 3 | $58 |
| Incyte Corporation | 3 | $56 |
Products named: DUPIXENT, TREMFYA, OTEZLA, SKYRIZI, NEMLUVIO, RINVOQ, TALTZ, Sotyktu.
Industry payments across OH — which companies pay providers there.
